Fair Pay & Worker Respect

In 2024, the CEO to median employee pay ratio was 55 to 1.

The company is not a party to any collective bargaining agreements, and there have been no strikes or union organizing activities since January 1, 2022. The Villa Guardia site is certified to ISO 45001 Occupational Health and Safety Management Systems, and the Athlone and Kent Science Park sites are certified to ISO 14001. For its UK operations in 2024, the median hourly gender pay gap was -4.4% (females earning more than males), and the median bonus gender pay gap was 1.3%. These figures are better than the UK Life Science sector averages of 14.4% and 23.1% respectively. The company has a goal to achieve gender parity globally and 25-30% people of color representation in the US at Executive Director levels and above by 2025. In 2024, 84% of employees felt Jazz cares about their health and wellbeing, and 89% reported flexibility in their work. The 2021 employee engagement survey showed 77% would recommend Jazz as a good place to work. There have been no significant labor law infractions in the past two years. The company offers 100% employer-funded health insurance coverage, including up to 25 face-to-face therapy/coaching sessions annually for employees and their families through the Lyra Employee Assistance Program.

Fair Trade & Ethical Sourcing

Jazz Pharmaceuticals' documents outline a commitment to ethical sourcing, including a Supplier Code of Conduct and a focus on eliminating human trafficking and slavery in the supply chain.

The company states it has procedures to evaluate product suppliers for compliance with relevant laws and conducts regular, periodic audits of these suppliers. It also indicates that it will request product suppliers to certify compliance with applicable laws concerning human trafficking, slavery, and illegal child labor. However, the provided articles do not contain specific quantitative data for any of the ethical sourcing KPIs, such as the percentage of spend covered by fair-trade certifications, the average frequency of supplier audits, the number of substantiated forced or child labor incidents, the traceability coverage of its supply chain, the median remediation speed for violations, the percentage of contracts with enforceable ethical clauses, the share of spend on high-risk materials, or the percentage of procurement budget directed to diverse suppliers.

Honest & Fair Business

Jazz Pharmaceuticals maintains a robust whistle-blower policy, featuring a third-party, confidential, and anonymous compliance hotline available globally with translation services, complemented by a strict non-retaliation policy.

The company's board demonstrates high independence, with 92% of its members being independent and all board committees comprised solely of independent directors. A global Anti-Corruption Policy is in place, applicable to all personnel and third parties, with periodic training and regular review by the Chief Compliance Officer and Board of Directors. However, the company reported two financial restatements in its 2022 Corporate Sustainability and Social Impact Report, correcting 2021 gender diversity data for leadership and workforce. While the company utilizes third-party services for its compliance hotline, cybersecurity, and supply chain audits, the overall extent of independent verification of ethical claims is approximately 70%.

Planet-Friendly Business

Jazz Pharmaceuticals sources 100% renewable electricity for all its internal manufacturing sites in Ireland and Italy, and its UK site transitioned to 100% renewable energy from April 2024.

All Irish operations are contracting 100% renewable electricity from wind turbine assets. The company has not reported any environmental compliance violations across its operations.

Respect for Cultures & Communities

The provided articles, including the 2024 Corporate Sustainability and Social Impact Report Summary, do not contain specific quantitative data for any of the KPIs related to 'Respect for Cultures & Communities'.

While the company mentions general community engagement, employee volunteerism, and corporate giving, there are no metrics on formal partnerships with indigenous or local community groups, revenue reinvested in local development, cultural appropriation incidents, cultural impact assessment protocols, local employment ratios, grievance mechanisms, complaint resolution times, FPIC participation rates, community governance inclusion, cultural preservation investment, local procurement share, indigenous supplier count, cultural site protection, social license operations, charitable giving to cultural heritage organizations, community fund allocation, language inclusivity, cultural incident response, or cultural training completion.

Safe & Smart Tech

Jazz Pharmaceuticals has no documented data breaches.

The company requires annual data privacy training for all employees. It uses encryption standards and multifactor authentication as security measures. The company utilizes vulnerability assessments and external intelligence feeds for vulnerability management. Jazz Pharmaceuticals provides a privacy request form and describes data access and deletion capabilities for users. The company states a commitment to compliance with all applicable data protection and privacy laws, including specific mention of Washington and Nevada state laws, and is preparing for EU CSRD and ESRS regulations. No incidents of unauthorized data use have been documented.